Gut Microbiota Influence on Mental Health

The gut microbiota has emerged as a pivotal regulator of mental health through bidirectional communication along the gut–brain axis. Variations in microbial communities can modulate neural, immune and endocrine pathways, influencing mood, cognition and stress resilience. Key mechanisms include production of neuroactive metabolites such as short‐chain fatty acids, regulation of systemic inflammation, and modification of neurotransmitter precursors. Dysbiosis—an imbalance in microbial composition—has been linked to depressive and anxiety‐like behaviours in animal models and to symptom severity in human cohorts. Restoration of a balanced microbiota through dietary modulation, probiotic supplementation or microbial transfer holds promise as a novel adjunct to conventional psychiatric therapies, with global implications for public health and personalised medicine.

Research from Nature Portfolio

Recent studies have elucidated causal pathways between gut microbial composition and depressive phenotypes. In one investigation of inflammatory depression, patients exhibited elevated Bacteroides and reduced Clostridium alongside altered short‐chain fatty acid profiles. Transplantation of patient‐derived microbiota into mice recapitulated depressive and anxiety‐like behaviours, while supplementation with Clostridium butyricum attenuated neuroinflammation and restored behavioural equilibrium. Another study using a chronic stress model demonstrated that faecal microbiota transfer from stressed donors induced despair‐like behaviour via suppression of central endocannabinoid signalling. Enhancement of endocannabinoid pathways or complementation with specific Lactobacillus strains counteracted these effects, revealing mechanistic links between microbial metabolites, central lipid signalling and mood regulation.

Gut Microbiota Influence on Mental Health publication trend

The graph below shows the total number of articles in gut microbiota influence on mental health across all publications each year (not limited to Nature Index journals).

Technical terms

Gut–brain axis: A complex network of neural, hormonal and immunological signalling connecting the gastrointestinal tract and the central nervous system.

Short‐chain fatty acids (SCFAs): Microbial fermentation products (e.g. acetate, propionate, butyrate) that modulate host metabolism, inflammation and neural function.

Fecal microbiota transplantation (FMT): Transfer of stool from a healthy donor into a recipient’s gastrointestinal tract to restore microbial diversity and function.

Dysbiosis: An imbalance in the composition or function of gut microbial communities associated with disease states.

Endocannabinoid system: A lipid signalling network involving endogenously produced cannabinoids and their receptors, which regulates mood, stress responses and synaptic plasticity.

References

1. Immunoregulatory role of the gut microbiota in inflammatory depression. Nature Communications (2024).
2. Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system. Nature Communications (2020).
3. Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice. Microbiome (2023).
4. Melatonin Ameliorates Depressive‐Like Behaviors in Ovariectomized Mice by Improving Tryptophan Metabolism via Inhibition of Gut Microbe Alistipes Inops. Advanced Science (2024).